Pnc Financial Services Group, Inc. Bio N Tech Se Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 967 shares of BNTX stock, worth $102,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares

967

Previous 969 0.21%

Holding current value

$102,821

Previous $110,000 20.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$91.06 - $126.88 $182 - $253	-2 Reduced 0.21%	967 $88,000
Q4 2024 Feb 07, 2025	SELL	$99.72 - $122.68 $8,376 - $10,305	-84 Reduced 7.98%	969 $110,000
Q3 2024 Nov 08, 2024	SELL	$78.36 - $124.66 $118,010 - $187,737	-1,506 Reduced 58.85%	1,053 $125,000
Q2 2024 Aug 09, 2024	BUY	$80.36 - $102.87 $3,696 - $4,732	46 Added 1.83%	2,559 $205,000
Q1 2024 May 10, 2024	SELL	$88.96 - $112.35 $6,227 - $7,864	-70 Reduced 2.71%	2,513 $231,000
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $158,456 - $196,523	1,743 Added 207.5%	2,583 $272,000
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $24,625 - $31,270	250 Added 42.37%	840 $91,000
Q2 2023 Aug 11, 2023	SELL	$102.58 - $129.66 $3,282 - $4,149	-32 Reduced 5.14%	590 $63,000
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $1,470 - $1,844	-12 Reduced 1.89%	622 $77,000
Q4 2022 Feb 10, 2023	SELL	$118.43 - $186.05 $55,898 - $87,815	-472 Reduced 42.68%	634 $95,000
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $1,276 - $1,831	-10 Reduced 0.9%	1,106 $149,000
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $22,185 - $33,523	180 Added 19.23%	1,116 $166,000
Q1 2022 May 12, 2022	SELL	$126.25 - $231.85 $208,060 - $382,088	-1,648 Reduced 63.78%	936 $159,000
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $86,656 - $145,008	400 Added 18.32%	2,584 $666,000
Q3 2021 Nov 05, 2021	BUY	$205.93 - $447.23 $311,778 - $677,106	1,514 Added 225.97%	2,184 $596,000
Q2 2021 Aug 06, 2021	SELL	$113.32 - $241.49 $5,666 - $12,074	-50 Reduced 6.94%	670 $149,000
Q1 2021 May 07, 2021	SELL	$85.73 - $119.5 $89,159 - $124,280	-1,040 Reduced 59.09%	720 $78,000
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $90,160 - $160,629	1,240 Added 238.46%	1,760 $143,000
Q2 2020 Aug 07, 2020	BUY	$38.58 - $66.74 $20,061 - $34,704	520 New	520 $34,000

Others Institutions Holding BNTX

# of Institutions

340

Shares Held

40M

Call Options Held

1.43M

Put Options Held

1.54M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Bio N Tech Se Transaction History